September 14, 2026
Indy is the world's first medicinal chemistry agent. Indy outperforms Claude Opus 5 and GPT-5.6 Sol in head-to-head benchmarks that include QC'ing new assay data, analyzing SAR, and the design/triage of analogs. NEW YORK -- Inductive Bio today launched Indy, an AI chemistry assistant, available to partners now. Inductive's medicinal chemists, computational chemists, and DMPK [...]
FairJourney Bio Consolidates Antibody Discovery Data with the Sapio Sciences Scientific AI Platform
September 14, 2026
Leading Antibody Discovery Expert Standardizes on the Sapio Scientific AI Platform to Accelerate Delivery for Biotechnology Clients The Sapio Scientific AI Platform will serve as the informatics backbone across FJBio's discovery and cell sciences operations, spanning sites in Cambridge, Porto and San Diego. Sapio Sciences' ELN and LIMS solutions will replace disconnected, paper-based data capture [...]
September 14, 2026
Validated on the CellXpress.ai® Automated Cell Culture System, the new workflow combines organoid biology expertise and laboratory automation to help researchers reduce variability, expand scale, and move discoveries toward impact with greater confidence SAN JOSE, Calif. and VANCOUVER, BC – Molecular Devices, a Danaher company and a leading provider of high-performance life science solutions, and STEMCELL [...]
ZEISS VersaXRM 5 Insight accelerates hybrid 3D X-ray imaging
September 14, 2026
New system combines X-ray microscopy and microCT for seamless multi-scale imaging in one connected workflow Jena, Germany - ZEISS Research Microscopy Solutions ZEISS today introduced ZEISS VersaXRM 5 Insight, a hybrid 3D X-ray microscope designed to help researchers and engineers understand samples faster. Combining X-ray microscopy and microCT in a single platform, the system delivers [...]
September 14, 2026
IonOpticks Aurora Series® 5 combines new CoreJet™ integrated emitter technology and a redesigned nanoZero® union with proven Aurora Series performance, delivering a step-change in robustness and lower cost per sample without compromising the depth and sensitivity researchers depend on. MELBOURNE, Australia – IonOpticks Aurora Series 5 represents the most significant robustness upgrade in the platform’s history. The [...]
September 11, 2026
Regulation Crowdfunding offering gives individuals the opportunity to invest in PulpFixin and support the company's mission to replace unnecessary plastic across life science laboratories. DAYTON, OH -- PulpFixin®, an innovator in sustainable laboratory products, announces the official launch of its investment offering on StartEngine, marking an important milestone in the company's growth and its mission to [...]
September 10, 2026
10x Genomics, a leader in single-cell and spatial biology, to combine its spatial biology technologies with Lunit's AI-powered H&E pathology analysis to advance oncology biomarker discovery SEOUL, South Korea -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that 10x Genomics, Inc. (Nasdaq: TXG) will incorporate Lunit's [...]
September 10, 2026
Tenth SBIR award brings Partillion’s total non-dilutive federal funding to more than $8 million and supports development of Cell-Cell-seq workflows LOS ANGELES -- Partillion Bioscience announced a two-year, $2.1 million NIH Small Business Innovation Research (SBIR) award from the National Institute of General Medical Sciences (NIGMS) to expand the company's Cell-Cell-seq workflows. Partillion's 10th SBIR [...]
September 9, 2026
Submission marks the first time data from the AVA™ Emulation System will be evaluated as part of the FDA qualification process, reinforcing confidence in scalable human-relevant liver models BOSTON -- Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, today announced it has submitted its FDA Innovative Science and Technology Approaches for New Drugs (ISTAND) [...]
Bracco Expands BubbleGen Cell Selection with CD3+ T Cell Isolation Kit
September 9, 2026
Microbubble-based technology enables magnetic bead-free cell selection for cell therapy research and development PRINCETON, N.J. -- Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, today announced the expansion of its BubbleGen™ cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit. The kit, built on [...]

